The Prescription Trap: Why Britain's Corporate Doctors Keep Prescribing Yesterday's Medicine for Tomorrow's Problems
When subsidiary performance falters, UK holding companies reflexively reach for the same intervention toolkit that has disappointed them before. This cycle of strategic repetition reveals a deeper problem: the confusion of activity with progress in corporate turnaround situations.